CAPTRUST Financial Advisors
PAVM icon

CAPTRUST Financial Advisors’s PAVmed PAVM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,168
Closed -$14.4K – 3100
2025
Q4 		$14.4K Hold
2,168
– – ﹤0.01% 2723
2025
Q3 		$28K Hold
2,168
– – ﹤0.01% 2592
2025
Q2 		$39K Hold
2,168
– – ﹤0.01% 2449
2025
Q1 		$46.9K Buy
+2,168
New +$45K ﹤0.01% 2286
2022
Q3 		– Sell
-9
Closed -$4K – 3430
2022
Q2 		$4K Hold
9
– – ﹤0.01% 4201
2022
Q1 		$5K Buy
9
+4
+80% +$2.97K ﹤0.01% 4163
2021
Q4 		$5K Hold
5
– – ﹤0.01% 4087
2021
Q3 		$19K Buy
5
+4
+400% +$12.6K ﹤0.01% 3202
2021
Q2 		$2K Buy
+1
New +$2.36K ﹤0.01% 4195

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CAPTRUST Financial Advisors's PAVM Position: Q1 2026 in Review

CAPTRUST Financial Advisors sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 2,168 shares — an estimated $14.4K sold.

CAPTRUST Financial Advisors first reported a position in PAVM in Q2 2021 and held it in 9 quarters. The position peaked at $46.9K in Q1 2025. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • CAPTRUST Financial Advisors reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,168 PAVmed shares in Q1 2026, an estimated $14.4K.
  • CAPTRUST Financial Advisors first reported a position in PAVmed in Q2 2021 and held it in 9 quarters.
  • CAPTRUST Financial Advisors's PAVmed position peaked at $46.9K in Q1 2025.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.